Peroxisome proliferator-activated receptor γ:: the more the merrier?

被引:53
作者
Argmann, CA
Cock, TA
Auwerx, J
机构
[1] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
[2] Genopole Strasbourg, Inst Clin Souris, F-67404 Illkirch Graffenstaden, France
关键词
atherosclerosis; longevity and bone; metabolism; mouse models; PPAR gamma;
D O I
10.1111/j.1365-2362.2005.01456.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The consequence of activating the nuclear hormone receptor, peroxisome proliferator-activated receptor gamma (PPARgamma), which coordinates adipocyte differentiation, validates the concept, 'you are what you eat'. Excessive caloric intake leads to fat formation if the energy from these nutrients is not expended. However, this evolutionary adaptation to store energy in fat, which can be released under the form of fatty acids, potent PPARgamma agonists, has become a disadvantage in today's affluent society as it results in numerous metabolic imbalances, collectively known as the metabolic syndrome. With the surge of human and genetic studies on PPARgamma function, the limitations to the benefits of PPARgamma signalling have been realized. It is now evident that the most effective strategy for resetting the balance of this thrifty gene is through its modulation rather than full activation, with the goal to improve glucose homeostasis while preventing adipogenesis. Finally, as more PPARgamma targeted pathways are revealed such as bone homeostasis, atherosclerosis and longevity, it is most certain that the PPARgamma thrifty gene hypothesis will evolve to incorporate these.
引用
收藏
页码:82 / 92
页数:11
相关论文
共 113 条
  • [1] A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy
    Agarwal, AK
    Garg, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) : 408 - 411
  • [2] Tyrosine Agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor γ
    Agostini, M
    Gurnell, M
    Savage, DB
    Wood, EM
    Smith, AG
    Rajanayagam, O
    Garnes, KT
    Levinson, SH
    Xu, HE
    Schwabe, JWR
    Willson, TM
    O'Rahilly, S
    Chatterjee, VK
    [J]. ENDOCRINOLOGY, 2004, 145 (04) : 1527 - 1538
  • [3] Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
    Akiyama, TE
    Sakai, S
    Lambert, G
    Nicol, CJ
    Matsusue, K
    Pimprale, S
    Lee, YH
    Ricote, M
    Glass, CK
    Brewer, HB
    Gonzalez, FJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) : 2607 - 2619
  • [4] PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
    Akune, T
    Ohba, S
    Kamekura, S
    Yamaguchi, M
    Chung, UI
    Kubota, N
    Terauchi, Y
    Harada, Y
    Azuma, Y
    Nakamura, K
    Kadowaki, T
    Kawaguchi, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) : 846 - 855
  • [5] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    Altshuler, D
    Hirschhorn, JN
    Klannemark, M
    Lindgren, CM
    Vohl, MC
    Nemesh, J
    Lane, CR
    Schaffner, SF
    Bolk, S
    Brewer, C
    Tuomi, T
    Gaudet, D
    Hudson, TJ
    Daly, M
    Groop, L
    Lander, ES
    [J]. NATURE GENETICS, 2000, 26 (01) : 76 - 80
  • [6] Yeast life-span extension by calorie restriction is independent of NAD fluctuation
    Anderson, RM
    Latorre-Esteves, M
    Neves, AR
    Lavu, S
    Medvedik, O
    Taylor, C
    Howitz, KT
    Santos, H
    Sinclair, DA
    [J]. SCIENCE, 2003, 302 (5653) : 2124 - 2126
  • [7] PPARγ, the ultimate thrifty gene
    Auwerx, J
    [J]. DIABETOLOGIA, 1999, 42 (09) : 1033 - 1049
  • [8] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
  • [9] Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)γ-2 with longevity
    Barbieri, M
    Bonafè, M
    Rizzo, MR
    Ragno, E
    Olivieri, F
    Marchegiani, F
    Franceschi, C
    Paolisso, G
    [J]. EXPERIMENTAL GERONTOLOGY, 2004, 39 (07) : 1095 - 1100
  • [10] Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
    Barroso, I
    Gurnell, M
    Crowley, VEF
    Agostini, M
    Schwabe, JW
    Soos, MA
    Maslen, GL
    Williams, TDM
    Lewis, H
    Schafer, AJ
    Chatterjee, VKK
    O'Rahilly, S
    [J]. NATURE, 1999, 402 (6764) : 880 - 883